Scarica l'app Stockscreener
66.57
0.14%
0.09
Pre-mercato:
66.31
-0.26
-0.39%
Precedente Chiudi:
$66.48
Aprire:
$67.07
Volume 24 ore:
684.47K
Relative Volume:
1.13
Capitalizzazione di mercato:
$3.60B
Reddito:
$155.82M
Utile/perdita netta:
$-40.42M
Rapporto P/E:
-93.76
EPS:
-0.71
Flusso di cassa netto:
$3.58M
1 W Prestazione:
+2.97%
1M Prestazione:
-11.87%
6M Prestazione:
+6.41%
1 anno Prestazione:
+20.45%
Intervallo 1D:
$65.75
$67.80
Intervallo di 1 settimana:
$63.62
$68.24
Portata 52W:
$47.88
$107.37
Arcellx Inc Stock (ACLX) Company Profile
Nome
Arcellx Inc
Settore
Industria
Telefono
240-327-0603
Indirizzo
800 BRIDGE PARKWAY, REDWOOD CITY
Confronta ACLX con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ACLX
Arcellx Inc
|
66.57 | 3.60B | 155.82M | -40.42M | 3.58M | -0.71 |
|
VRTX
Vertex Pharmaceuticals Inc
|
427.89 | 110.19B | 10.63B | -479.80M | -1.35B | -1.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
687.80 | 75.58B | 13.85B | 4.65B | 3.32B | 40.41 |
|
ARGX
Argen X Se Adr
|
647.39 | 38.71B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
264.99 | 34.18B | 2.09B | -332.26M | 16.06M | -2.62 |
|
BNTX
Biontech Se Adr
|
117.25 | 28.11B | 3.30B | -501.07M | 1.03B | -2.1146 |
Arcellx Inc Stock (ACLX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-10-08 | Iniziato | Redburn Atlantic | Buy |
| 2024-09-03 | Iniziato | Cantor Fitzgerald | Overweight |
| 2024-05-31 | Iniziato | Piper Sandler | Overweight |
| 2024-03-07 | Iniziato | Morgan Stanley | Overweight |
| 2024-01-04 | Reiterato | Needham | Buy |
| 2023-12-19 | Iniziato | Scotiabank | Sector Outperform |
| 2023-10-30 | Iniziato | TD Cowen | Outperform |
| 2023-10-17 | Iniziato | UBS | Buy |
| 2023-05-18 | Iniziato | Truist | Buy |
| 2023-04-14 | Iniziato | Robert W. Baird | Outperform |
| 2023-03-14 | Iniziato | Stifel | Buy |
| 2023-02-13 | Iniziato | H.C. Wainwright | Buy |
| 2022-12-13 | Ripresa | BofA Securities | Buy |
| 2022-10-31 | Iniziato | Guggenheim | Buy |
| 2022-10-27 | Iniziato | Needham | Buy |
| 2022-07-20 | Iniziato | Canaccord Genuity | Buy |
| 2022-03-01 | Iniziato | BofA Securities | Buy |
| 2022-03-01 | Iniziato | SVB Leerink | Outperform |
Mostra tutto
Arcellx Inc Borsa (ACLX) Ultime notizie
Short Interest in Arcellx, Inc. (NASDAQ:ACLX) Expands By 6.6% - MarketBeat
Arcellx, Inc.: Trying To Build A Better Myeloma Cell Therapy - Seeking Alpha
Arcellx director Kavita Patel sells $98,801 in stock By Investing.com - Investing.com Australia
Arcellx, Inc. (NASDAQ:ACLX) Director Kavita Patel Sells 1,500 Shares - MarketBeat
Arcellx director Kavita Patel sells $98,801 in stock - Investing.com India
(ACLX)Analyzing Arcellx's Short Interest - Benzinga
Oversold Conditions For Arcellx (ACLX) - Nasdaq
Arcellx, Inc. (NASDAQ:ACLX) Insider Sells $261,820.57 in Stock - MarketBeat
Arcellx's chief medical officer sells shares worth $581,315 By Investing.com - Investing.com Australia
arcellx CEO Elghandour sells stock worth $2.26 million By Investing.com - Investing.com Nigeria
Arcellx CFO Michelle Gilson sells shares worth $700,959 By Investing.com - Investing.com Australia
arcellx CEO Elghandour sells stock worth $2.26 million - Investing.com
Arcellx CFO Michelle Gilson sells shares worth $700,959 - Investing.com India
Arcellx Breaks Below 200-Day Moving AverageNotable for ACLX - Nasdaq
Arcellx, Inc. (NASDAQ:ACLX) Shares Sold by JPMorgan Chase & Co. - MarketBeat
Arcellx's chief medical officer sells shares worth $498,795 By Investing.com - Investing.com Australia
Arcellx CFO Michelle Gilson sells $831,378 in stock By Investing.com - Investing.com Nigeria
Principal Financial Group Inc. Has $336,000 Stock Position in Arcellx, Inc. (NASDAQ:ACLX) - MarketBeat
Arcellx CEO Rami Elghandour sells shares worth $2.24 million By Investing.com - Investing.com Australia
Arcellx chief medical officer sells shares worth $498,795 By Investing.com - Investing.com Canada
Arcellx chief medical officer sells shares worth $498,795 - Investing.com
Christopher Heery Sells 3,061 Shares of Arcellx, Inc. (NASDAQ:ACLX) Stock - MarketBeat
Christopher Heery Sells 3,301 Shares of Arcellx, Inc. (NASDAQ:ACLX) Stock - MarketBeat
Arcellx CEO Rami Elghandour sells shares worth $2.24 million - Investing.com
Arcellx CFO Michelle Gilson sells $831,378 in stock - Investing.com India
Arcellx (NASDAQ:ACLX) Sees Unusually-High Trading VolumeHere's Why - MarketBeat
Arcellx, Inc. (NASDAQ:ACLX) Receives $105.93 Consensus Price Target from Analysts - MarketBeat
Viking stock among buyout targets: Oppenheimer (VKTX:NASDAQ) - Seeking Alpha
(ACLX) On The My Stocks Page - Stock Traders Daily
Arcellx Stock Earns 82 Relative Strength Rating - Yahoo! Voices
arcellx director Kavita Patel sells shares worth $115,450 - Investing.com India
arcellx director Kavita Patel sells shares worth $115,450 By Investing.com - Investing.com Nigeria
5 Biotech Breakthrough Stocks to Watch in 2025 - Yahoo Finance
Arcellx Inc Azioni (ACLX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
4.81%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):